IMMUNITOR
Biotechnology Research • 
Winchester, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | 1 Winnall Valley Road, Unit 53, Basepoint Business Centre, Winchester, Hampshire SO23 0LD, GB |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Key Contact at IMMUNITOR
Aldar Bourinbaiar
Chief Executive Officer
About IMMUNITOR
Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill which is easy to administer, has low manufacturing cost, stable, safe, and effective. IMMUNITOR LTD is a subsidiary of Company Immunitor Inc. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific Immunity products are registered in several Asian and African countries. Immunitor has developed and currently manufactures seven products as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, cancer, atherosclerosis/obesity, and a broad spectrum of bacterial, fungal infections.
IMMUNITOR revenue & valuation
| Annual revenue | $1,200,000 |
| Revenue per employee | $172,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
IMMUNITOR has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
IMMUNITOR has never raised funding before.
IMMUNITOR Tech Stack
Discover the technologies and tools that power IMMUNITOR's digital infrastructure, from frameworks to analytics platforms.
Web servers
Operating systems
United States
Singapore
Frequently asked questions
4.8
40,000 users
